Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. [electronic resource]
Producer: 20100202Description: 874-81 p. digitalISSN:- 1651-226X
- Adenocarcinoma -- blood
- Aged
- Aged, 80 and over
- Androgen Antagonists -- therapeutic use
- Combined Modality Therapy
- Gonadotropin-Releasing Hormone -- therapeutic use
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Neoplasms, Hormone-Dependent -- blood
- Prognosis
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Radiotherapy Dosage
- Radiotherapy, High-Energy
- Risk Factors
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.